Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CI
STRONG BUYAPPROVEThe Cigna Group · Healthcare · United States · $76.6B · Avg Vol: $468M/d
The Cigna Group generates substantial free cash flow from health services and pharmacy benefits, funds a large ongoing buyback and a rising dividend, and screens cheap on value (V77). Its exit from Medicare Advantage removed the segment causing the worst cost-trend volatility across the sector. The trivial insider selling is routine and nothing adverse is known on accounting or solvency.
COMPANY DESCRIPTION
The Cigna Group is a global health services organization providing a comprehensive suite of health insurance, pharmacy benefits management (PBM) through Express Scripts, and other health solutions. Its competitive moat is built on the integrated PBM and health plan model, leveraging significant scale, extensive provider networks, and data analytics to optimize care and manage costs. Cigna is a major player in the U.S. and international healthcare markets, offering holistic health and wellness programs.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 179.4B | 194.1B | 246.1B | 273.9B | 15.1% | 277.9B | 283.4B | 295.7B | 3.9% |
| EPS | 22.33 | 17.65 | 12.54 | 22.61 | 0.4% | 23.79 | 23.04 | 25.37 | 5.9% |
| Shares | 298.7M | 292.5M | 273.8M | 263.5M | -11.8% | 264.5M | — | — | — |
| Debt | 31.1B | 30.9B | 32.0B | 31.5B | 0.4% | 30.9B | — | — | — |
| Equity | 44.7B | 46.2B | 41.0B | 41.7B | -2.3% | — | — | — | — |
| Op CF | 8.7B | 11.8B | 10.4B | 9.6B | 3.5% | 8.8B | — | — | — |
| Inv CF | 3.1B | -5.2B | -2.1B | -4.4B | — | — | — | — | — |
| Fin CF | -11.2B | -4.3B | -7.6B | -6.4B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CI | The Cigna Group(you) | $76.6B | 97 | STRONG BUY |
| ELV | Elevance Health, Inc. | $81.9B | 94 | STRONG BUY |
| CVS.DE | CVS Health Corporation | $134.2B | 93 | STRONG BUY |
| HUM | Humana Inc. | $46.7B | 86 | STRONG BUY |
| CNC | Centene Corporation | $31.3B | 92 | STRONG BUY |
| UNH.DE | UnitedHealth Group Incorporated | $387.0B | 94 | STRONG BUY |
| OSCR | Oscar Health, Inc. | $8.5B | 88 | STRONG BUY |
| MOH | Molina Healthcare, Inc. | $10.3B | 77 | BUY |
| PGNY | Progyny, Inc. | $2.4B | 97 | STRONG BUY |
| CLOV | Clover Health Investments, Corp. | $2.3B | 73 | BUY |
Peer medians: ROE 2.1% · P/E 23.4x · Gross margin 50.1%